FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for desmopressin acetate from Bauch & Lomb Incorporated under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus
• Hemophilia
• Nocturnal Enuresis
• Von Willebrand Disease

Drugs mentioned

• Desmopressin Acetate (Desmopressin acetate)

Snippet

SUPPL AP for DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)